HeraMED (ASX:HMD) Common Stock: A$41.45 Mil (As of Dec. 2025)


What is HeraMED Common Stock?

HeraMED ASX:HMD +2.38% Common Stock is A$41.45 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

HeraMED's quarterly common stock declined from Dec. 2024 (A$38.93 Mil) to Jun. 2025 (A$38.87 Mil) but then increased from Jun. 2025 (A$38.87 Mil) to Dec. 2025 (A$41.45 Mil).

HeraMED's annual common stock increased from Dec. 2023 (A$35.39 Mil) to Dec. 2024 (A$38.93 Mil) and increased from Dec. 2024 (A$38.93 Mil) to Dec. 2025 (A$41.45 Mil).

HeraMED Common Stock Historical Data

* Premium members only.

The historical data trend for HeraMED's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeraMED Common Stock Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 22.74 32.57 35.39 38.93 41.45

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.39 35.80 38.93 38.87 41.45

HeraMED Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$41.45 Mil mean?
HeraMED (ASX:HMD) has a Common Stock of A$41.45 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on HeraMED and its competitors.
Is HeraMED's Common Stock too high?
HeraMED's current Common Stock is A$41.45 Mil.
How does HeraMED's Common Stock compare to ABT and SYK?
HeraMED's Common Stock of A$41.45 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on HeraMED and its competitors. HeraMED's current Common Stock is A$41.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeraMED stock overvalued right now?
Based on GuruFocus' analysis, HeraMED (ASX:HMD) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.04 — trading 115% above its estimated fair value. The current Common Stock is A$41.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For HeraMED (ASX:HMD), the current Common Stock is A$41.45 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeraMED Business Description

Other Exchanges 1I4:Germany
Address 117 Camberwell Road, Level 1 - Suite 1, Hawthorn East, Melbourne, VIC, AUS, 3123
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.